Deutscher Basketball Bund (DBB), the German Basketball Federation, has reported an anti-doping rule violation against the Player for the use of the prohibited substance insulin.
On 23 December 2011 the Player applied to the Nationale Anti-Doping Agentur Deutschland (NADA), German National Anti-Doping Agency, for a Therapeutic Use Exemption (TUE) for insulin after a doping control on 17 December 2011. Analyses of Player’s sample showed no indication for use of substances include in the 2011 WADA Prohibited List. Player’s TUE request was granted in January 2012.
After notification the Player filed a statement in his defence and he was heard for the DBB Anti-Doping Commission in March 2012. Player stated he has diabetes since the age of three and had taken insulin ever since. Player was not aware of insulin being a prohibited substance. In 2007 he had contacted FIBA and assumed that the reply of FIBA’s Anti-Doping Officer was enabling him to play anywhere in Europe without a TUE.
On 23 May the DBB Anti-Doping Commission decided to impose a 6 month period of ineligibility on the Player starting on 28 March 2012.
Hereafter the FIBA decides to adopt the DBB Anti-Doping Commission's decision. This decision does not mention details regarding the committed anti-doping rule violations.
